Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
56.21
+0.98 (+1.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For July 29, 2021
July 29, 2021
Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is...
Via
Benzinga
Why Translate Bio Stock Soared Today
August 03, 2021
The biotech is being bought for $3.2 billion.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
August 03, 2021
Toward the end of trading Tuesday, the Dow traded up 0.64% to 35,059.40 while the NASDAQ rose 0.34% to 14,731.57. The S&P also rose, gaining 0.65% to 4,415.65. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Translate Bio Stock Rockets As Sanofi Jumps Into mRNA Technology With $3.2 Billion Takeover
August 03, 2021
Sanofi is jumping into the messenger RNA game with the $3.2 billion acquisition of Translate Bio, leading TBIO stock to soar Tuesday.
Via
Investor's Business Daily
Exposures
COVID-19
Sanofi Acquires Translate Bio For $38 Per Share In Cash Or $3.2B
August 03, 2021
Sanofi has entered into a definitive agreement with Translate Bio for $38.00 per share in cash, which represents a total equity value of $3.2B a fully diluted basis.
Via
Talk Markets
Sanofi Bets Big On mRNA Push With Translate Bio Acquisition For $3.2B: Highlights
August 03, 2021
A year after paying Translate Bio Inc (NASDAQ: TBIO) a whopping $425 million to develop mRNA vaccines for infectious diseases, including COVID-19, Sanofi...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...
Via
Benzinga
Sanofi (SNY) Q2 2021 Earnings Call Transcript
July 30, 2021
SNY earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast
July 29, 2021
Sanofi SA (NASDAQ: SNY) has raised its 2021 profit forecast after its vaccines and blockbuster eczema treatment Dupixent helped boost second-quarter results. Q2 2021...
Via
Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
July 29, 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) have announced topline results from Phase 3 trial evaluating Dupixent (...
Via
Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing
July 27, 2021
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sanofi SA's (NASDAQ:...
Via
Benzinga
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
July 22, 2021
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) started their collaboration in chronic obstructive pulmonary disorder (COPD) to target all...
Via
Benzinga
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
July 20, 2021
EMA's human medicines committee has kicked off a rolling review of a COVID-19 vaccine from Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (...
Via
Benzinga
Exposures
COVID-19
Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval
July 19, 2021
The FDA has approved Sanofi SA's (NASDAQ: SNY) fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of...
Via
Benzinga
Exposures
Product Safety
5 French Stocks To Consider For Bastille Day
July 14, 2021
Bastille Day is France’s National Day, celebrating the Storming of the Bastille on July 14, 1789, a key turning point in the French Revolution. And while the French concept...
Via
Benzinga
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
July 08, 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline Plc (NYSE: GSK) have received approval from the Drug Controller General of India (DCGI) for a late-stage...
Via
Benzinga
Exposures
COVID-19
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
July 07, 2021
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients...
Via
Benzinga
Exposures
COVID-19
Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
June 29, 2021
Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-...
Via
Benzinga
Exposures
COVID-19
Sanofi Invests To Build Internal Capabilities in mRNA
June 29, 2021
Sanofi SA (NASDAQ: SNY) is working towards its R&D approach around mRNA to accelerate the development and delivery of next-generation vaccines. The company will ...
Via
Benzinga
Saint Warren
June 28, 2021
Today the WTI oil price rose further up over 1%.
Via
Talk Markets
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
Sanofi Divests 16 Consumer Health Brands To Stada
June 28, 2021
Amid a reorganization scheme aimed at slashing costs and prioritizing blockbuster immunology Dupixent, Sanofi SA (NASDAQ: SNY) will offload 16 consumer health...
Via
Benzinga
Sanofi's Soliqua Shows Improved Blood Sugar Control Without Weigh Gain Against Premixed Insulin
June 28, 2021
Sanofi SA (NASDAQ: SNY) has announced new study data of Soliqua 100/33 (insulin glargine and lixisenatide injection) that met its two primary endpoints and all key...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
June 28, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
AstraZeneca's Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV
June 28, 2021
AstraZeneca Plc (NASDAQ: AZN) announced data from the MEDLEY Phase 2/3 trial evaluating nirsevimab in infants at high risk of respiratory syncytial virus (RSV). The trial...
Via
Benzinga
Sanofi - Regeneron's Immunotherapy Scores European Approval For Skin And Lung Cancer Settings
June 25, 2021
The European Commission (EC) has approved Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo (cemiplimab) for two...
Via
Benzinga
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
June 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.